This inventor holds 1 USPTO granted patent. Top assignee: University of California. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: Antonio V Ferrer-Monteil: Innovator in Neurotransmitter Research
Introduction
Antonio V Ferrer-Monteil is a prominent inventor based in Alicante, Spain. He has made significant contributions to the field of neuroscience through his innovative research and patents. His work focuses on the development of peptide inhibitors that have the potential to revolutionize the treatment of neurological disorders.
Latest Patents
Ferrer-Monteil holds a patent for "Peptide inhibitors of neurotransmitter secretion by neuronal cells." This invention consists of peptides that inhibit the secretion of neurotransmitters from synaptic vesicles. The peptides are believed to mimic the activity of neurotoxins produced by various botulinum serotypes. Structurally, these peptides are comprised of amino acid fragments from substrate binding domains selected from three proteins: SNAP-25, VAMP-2, and syntaxin. Certain peptides exhibit strong inhibitory activity, achieving a 50% or greater decline in neurotransmitter release at nanomolar concentrations. These peptides are suited for use as substitutes for Clostridium neurotoxins in clinical applications and for targeted drug delivery into neural cells.
Career Highlights
Ferrer-Monteil is affiliated with the University of California, where he continues to advance his research in neuroscience. His innovative work has garnered attention in the scientific community, contributing to the understanding of neurotransmitter regulation.
Collaborations
He has collaborated with notable colleagues, including Mauricio Montal and Jaume M Canaves, to further enhance the impact of his research.
Conclusion
Antonio V Ferrer-Monteil is a key figure in the field of neurotransmitter research, with a patent that holds promise for clinical applications. His contributions are paving the way for new therapeutic strategies in neuroscience.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
